News
52mon MSN
Everton fan and broadcaster David Downie spoke to BBC Radio Merseyside about Dominic Calvert-Lewin's departure: "Right now we ...
1don MSN
Aubrey O’Day has shared her reaction to the results of Sean “Diddy” Combs ‘ trial, which concluded Wednesday (July 2) with a ...
5 Live listeners have their say with Nicky Campbell.
BBC Breakfast and 'The Rest Is Money' presenter shared her views on the teary Chancellor.
A group of faith leaders, community advocates, and activists continues to call on the Monroe County District Attorney’s ...
Results from the Phase III BASIS trial show that once-weekly subcutaneous Hympavzi reduced annualized bleeding rates by 93% ...
Approved eight months ago for a certain class of patients with both hemophilia A or B, Pfizer’s Hympavzi has now shown its ...
Responses cited increasing workloads, shrinking autonomy, mounting interference from hospital administrators and insurance ...
The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with ...
ICE raids are disrupting worksites across the country, particularly construction sites, as President Trump’s mass deportation ...
On June 26, Pfizer announced positive topline results from its Phase 3 BASIS study evaluating HYMPAVZI (marstacimab) for ...
Pfizer said a late-stage study of its Hympavzi hemophilia drug met its key goals in patients with the blood-clotting disorder who have inhibitors that can render some treatments ineffective.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results